製品名:(R)-O-ISOPROPYLIDENE GLYCEROL MESYLATE

IUPAC Name:[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl methanesulfonate

CAS番号:83461-40-9
分子式:C7H14O5S
純度:95%+
カタログ番号:CM1032311
分子量:210.24

包装単位 有効在庫 価格(USD) 数量

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:83461-40-9
分子式:C7H14O5S
融点:-
SMILESコード:CC1(OC[C@@H](O1)COS(=O)(=O)C)C
密度:
カタログ番号:CM1032311
分子量:210.24
沸点:
MDL番号:
保管方法:

Category Infos

Dioxolanes
Dioxolane is a heterocyclic acetal with the formula (CH2)2O2CH2. It is related to tetrahydrofuran by exchanging an oxygen for the CH2 group. The isomer 1,2-dioxolane (in which the two oxygen centers are adjacent) is a peroxide. 1,3-Dioxolane is used as solvent and comonomer in polyacetal. The dioxolane-type and their hydrogenolysis can provide very valuable partially protected building blocks either for oligosaccharide syntheses or sugar transformations.

Column Infos

Mirdametinib
SpringWorks Therapeutics announced that the Company has initiated a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for mirdametinib, an investigational MEK inhibitor, in pediatric and adult patients with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN). The NDA submission includes data from the Phase 2b ReNeu trial. The primary endpoint was confirmed objective response rate (ORR). The BICR-confirmed objective response rate was 52% in pediatric patients and 41% in adult patients. Mirdametinib treatment showed deep and durable responses and demonstrated significant improvements in key secondary patient-reported outcome measures.

Related Products